P21-activated kinase 4 (PAK4) as a predictive marker for gemcitabine in pancreatic cancer cell line

被引：0
|
作者：
Moon, Sung Ung [1 ]
Kim, Jin Won [1 ]
Sung, Ji Hea [1 ]
Kang, Mi Hyun [1 ]
Chang, Hyun [1 ]
Lee, Jeong Ok [1 ]
Kim, Yu Jung [1 ]
Lee, Keun Wook [1 ]
Kim, Jee Hyun [1 ]
Bang, Soo Mee [1 ]
Lee, Jong Seok [1 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-912
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
912
引用
收藏
页数：1
相关论文
共 50 条
  • [21] P21-ACTIVATED KINASE 4 (PAK4) REGULATES MULTIPLE MYELOMA (MM) CELL GROWTH AND SURVIVAL BY MODULATION OF CRITICAL TRANSCRIPTIONAL PATHWAYS: THERAPEUTIC APPLICATION OF PAK4 ALLOSTERIC INHIBITORS
    Fulciniti, M. T.
    Oliva, S.
    Amodio, N.
    Roccaro, A.
    Bandi, R. L.
    Daisy, H.
    Cagnetta, A.
    Senapedis, W.
    Baloglu, E.
    Anderson, K. C.
    Ghobrial, I.
    Munshi, N. C.
    HAEMATOLOGICA, 2015, 100 : 78 - 79
  • [22] P21-activated kinase 4-Not just one of the PAK
    Dart, Anna E.
    Wells, Claire M.
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2013, 92 (4-5) : 129 - 138
  • [23] PRESENCE OF THE P21-ACTIVATED KINASE, PAK4, IN PANCREATIC ACINAR CELLS AND ITS ACTIVATION BY NUMEROUS GASTROINTESTINAL HORMONES AND GROWTH FACTORS
    Ramos, Irene
    Nuche-Berenguer, Bernardo
    Moreno, Paola
    Mantey, Samuel A.
    Iordanskaia, Tatiana
    Jensen, Robert T.
    GASTROENTEROLOGY, 2017, 152 (05) : S902 - S902
  • [24] Loss of p21-activated kinase Mbt/PAK4 causes Parkinson-like phenotypes in Drosophila
    Puetz, Stephanie M.
    Kram, Jette
    Rauh, Elisa
    Kaiser, Sophie
    Toews, Romy
    Lueningschroer-Wang, Yi
    Rieger, Dirk
    Raabe, Thomas
    DISEASE MODELS & MECHANISMS, 2021, 14 (06)
  • [25] INHIBITION OF P21-ACTIVATED KINASE 4 (PAK4) REVERTS IMMUNE EXCLUSION AND RESTORES ANTITUMOR IMMUNITY IN THE TUMOR MICROENVIRONMENT
    Zhou, Yu 'Jerry'
    Chu, Gina
    Hendrickson, Eleanore
    Gullo-Brown, Johnni
    Chavez, Brandy
    McAlpine, Indrawan
    Rui, Eugene
    Doran, Shawn
    Timofeevski, Sergei
    Heyen, Jonathan
    Kinong, Jennifer
    Tang, Szu-Yu
    Oyer, Jon
    Rayannavar, Vinayak
    Nager, Andrew
    Ching, Keith
    Shi, Stephanie
    Bhadra, Rajarshi
    Dillon, Christopher
    Gururajan, Murali
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A768 - A768
  • [26] Prognostic value of p21-activated kinase 4 in resected pancreatic cancer
    Park, Sehhoon
    Kim, Jin Won
    Kim, Haeryoung
    Kim, Ji-Won
    Kim, Yu Jung
    Lee, Keun-Wook
    Kim, Jee Hyun
    Kim, Jai Hwan
    Hwang, Jin-Hyeok
    Choi, Young Rok
    Cho, Jai Young
    Yoon, Yoo-Seok
    Han, Ho-Seong
    APMIS, 2017, 125 (08) : 699 - 707
  • [27] Molecular basis for integrin adhesion receptor binding to p21-activated kinase 4 (PAK4) (vol 5, 1257, 2022)
    Ha, Byung Hak
    Yigit, Sezin
    Natarajan, Nalini
    Morse, Elizabeth M.
    Calderwood, David A.
    Boggon, Titus J.
    COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [28] Design, synthesis and biological evaluation of 1-phenanthryl-tetrahydroisoquinoline derivatives as novel p21-activated kinase 4 (PAK4) inhibitors
    Song, Shuai
    Li, Xiaodong
    Guo, Jing
    Hao, Chenzhou
    Feng, Yan
    Guo, Bingyu
    Liu, Tongchao
    Zhang, Qiaoling
    Zhang, Zhen
    Li, Ruijuan
    Wang, Jian
    Lin, Bin
    Li, Feng
    Zhao, Dongmei
    Cheng, Maosheng
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2015, 13 (12) : 3803 - 3818
  • [29] Interaction of paxillin with p21-activated kinase (PAK)
    Hashimoto, S
    Tsubouchi, A
    Mazaki, Y
    Sabe, H
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 172A - 173A
  • [30] Activation of p21-activated kinase (γ-PAK) by sphingosine
    Tuazon, PT
    Roig, J
    Gatti, A
    Traugh, JA
    FASEB JOURNAL, 1999, 13 (07): : A1490 - A1490
12345